U.S. market Closed. Opens in 11 hours 48 minutes

OMIC | Singular Genomics Systems, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.91M765.00KN/AN/AN/A
Cost of Revenue3.47M789.00K1.13M639.00K350.00K
Gross Profit-558.00K-24.00K-1.13M-639.00K-350.00K
Operating Expenses102.24M93.46M61.28M27.53M12.77M
Selling, General & Admin54.48M47.26M28.62M6.29M2.29M
Research & Development47.76M46.20M32.66M21.25M10.48M
Other Operating ExpensesN/AN/A405.00KN/AN/A
Operating Income-102.80M-93.49M-61.28M-27.53M-12.77M
Other Expenses / Income7.98M2.61M-37.49M-411.00K446.00K
Before Tax Income-94.82M-90.88M-98.77M-27.95M-12.32M
Income Tax Expenses9.08M-2.61M118.00K718.00K17.00K
Net Income-94.82M-88.27M-98.89M-28.66M-12.34M
Interest Expenses1.10M763.00K846.00K718.00K17.00K
Basic Shares Outstanding72.80M71.15M72.44M69.32M69.32M
Diluted Shares Outstanding72.80M71.15M72.44M69.32M69.32M
EBITDA-86.50M-90.12M-60.55M-26.39M-11.96M
EBITDA Margin-2,971.35%-11,779.87%0.00%0.00%0.00%
EBIT-84.64M-90.12M-97.92M-27.23M-12.31M
EBIT Margin-2,907.49%-11,779.87%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙